Regenerative Medicine
MOTS-c
Mitochondrial longevity peptide — metabolic optimization, insulin sensitivity, and cellular energy restoration.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a groundbreaking peptide encoded within mitochondrial DNA — not nuclear DNA — making it unique among peptide therapeutics. Discovered in 2015 and published in Cell Metabolism, MOTS-c is a powerful metabolic regulator that activates AMPK, the master metabolic switch, to improve insulin sensitivity, cellular energy efficiency, and longevity gene expression. It mimics many of the effects of exercise and caloric restriction at the cellular level, without requiring either.
Mechanism: MOTS-c translocates from mitochondria to the nucleus under metabolic stress, where it binds and regulates ARE (Antioxidant Response Element) genes. It inhibits the folate cycle and de novo purine biosynthesis, leading to AMPK activation and improved metabolic flexibility. MOTS-c also directly modulates the gut microbiome and reduces chronic low-grade inflammation. Dosing protocol: 5–10 mg subcutaneously 1–2x/week. Exercise timing — many protocols dose 30–60 minutes before exercise for amplified performance and metabolic benefits. Cycle length: 4–12 weeks with rest periods; can be used long-term in monthly maintenance protocols. Contraindications: Limited human safety data compared to BPC-157/TB-500, though preclinical profiles are excellent. Use with caution in patients on metformin (both activate AMPK — additive effect). Not recommended during pregnancy. Ideal for patients on GLP-1/weight loss programs, hormone optimization protocols, or those with metabolic syndrome and type 2 diabetes.
Key Benefits
Your Visit
What to expect
Metabolic Baseline
Fasting insulin, HbA1c, fasting glucose, and lipid panel establish metabolic health starting point.
Protocol Initiation
5–10 mg MOTS-c weekly subQ prescribed. Timing optimized around exercise schedule.
Lifestyle Integration
Exercise protocol and nutritional guidance complement MOTS-c's AMPK activation for synergistic metabolic benefits.
Biomarker Review
Fasting insulin, glucose, and HbA1c reassessed at 8–12 weeks. Dose and cycle adjusted to findings.
Common Questions
Frequently asked
Is MOTS-c the same as exercise?
MOTS-c activates many of the same molecular pathways as aerobic exercise — particularly AMPK activation and mitochondrial biogenesis. It amplifies the benefits of exercise rather than replacing it.
Who benefits most from MOTS-c?
Patients with metabolic syndrome, insulin resistance, type 2 diabetes, obesity, or significant cognitive decline related to brain energy dysregulation. Also excellent for biohackers focused on longevity optimization.
Can MOTS-c be combined with GLP-1 therapy?
Yes — MOTS-c and GLP-1 agents work through complementary mechanisms and are a powerful combination for metabolic health, weight loss, and insulin sensitivity.
How long until metabolic improvements are noticeable?
Fasting insulin and glucose improvements are often measurable within 4 weeks. Body composition changes require 8–12 weeks of consistent protocol adherence.
Start here
Book now to talk through whether mots-c is the right fit for your goals, timeline, and recovery plan.
Book now →Related Protocols